Hims & Hers Health, Inc. Financials

Market Capitalization $10.74 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	70.56
Forward PE	104.30
Price to Sales TTM	$6.02
Price to Book MRQ	$19.53
Enterprise to Revenue	6.11
Enterprise to EBITDA	79.16

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	9.21%
Operating Margin	10.12%
Return on Assets TTM	10.76%
Return on Equity TTM	36.79%

Income Statement

Revenue TTM	$1,784,353,024
Revenue per Share TTM	$8.18
Quarterly Revenue Growth	110.70%
Gross Profit TTM	$1,374,728,960
EBITDA	$132,260,000
Net Income to Common TTM	$164,395,008
Diluted EPS TTM	$0.68
Quarterly Earnings Growth YoY	344.70%

Balance Sheet

Total Cash MRQ	$322,671,008
Total Cash per Share MRQ	$1.44
Total Debt MRQ	$
Total Debt to Equity MRQ	11.54
Current Ratio MRQ	1.59
Book Value per Share MRQ	$2.46

Cash Flow

Operating Cash Flow TTM	$334,336,000
Levered Free Cash Flow TTM	$213,447,872

HIMS Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	220,837,209
Float Shares	194,534,214
Avg 10 Volume	60,639,610
Avg 30 Volume	None
Shares Short	61,690,896
Short Ratio	1.47
Short % of Shares	34.23%
% Held by Insiders	11.13%
% Held by Institutions	74.54%

Stock Price Summary

Beta	2.10
Fifty Two Week Low	$13.47
Fifty Two Week High	$72.98
Fifty Two Week Change	56.69%
Day 50 MA	$50.58
Day 200 MA	$34.73

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date